Pharmacokinetic Study of Topical Phenylephrine
- Conditions
- Chemotherapy Induced AlopeciaChemotherapy Side Effects
- Registration Number
- NCT07033845
- Lead Sponsor
- Applied Biology, Inc.
- Brief Summary
Pharmacokinetic Study of Topical Phenylephrine
- Detailed Description
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Topical Phenylephrine Applied to the Scalp in Healthy Adult Females
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 24
- Healthy females, age 18-55
- BMI: 18-30 kg/m²
- Fitzpatrick Skin Types I-IV (to standardize absorption risk)
- Scalp free from irritation, dermatologic disease, or damage
- Able to refrain from using other topical scalp products
- History of cardiovascular disease, hypertension, or arrhythmia
- Scalp infections, wounds, or significant hair loss
- Recent use of medications that interfere with CYP enzymes or adrenergic systems
- Known sensitivity to phenylephrine or ethanol
- Positive drug screen or abnormal ECG at screening
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Primary Outcome Measures
Name Time Method Pharmacokinetic profile of phenylephrine Week [0,3] Determine the amount of phenylephrine and its metabolites in serum daily scalp application of topical phenylephrine for a period of 3 weeks
- Secondary Outcome Measures
Name Time Method Safety and tolerability of phenylephrine Week [0, 3] Determine blood pressure and dermatological adverse events following daily scalp application of topical phenylephrine for a period of 3 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Rome ("G. Marconi")
🇮🇹Rome, Italy
University of Rome ("G. Marconi")🇮🇹Rome, ItalyAndy Goren, MDContact16507040850clinicalstudies@appliedbiology.com